A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition

被引：64

作者：

Mahoney, Christopher E. ^{[1
]}

Pirman, David ^{[1
]}

Chubukov, Victor ^{[1
]}

Sleger, Taryn ^{[1
]}

Hayes, Sebastian ^{[1
]}

Fan, Zi Peng ^{[1
]}

Allen, Eric L. ^{[1
]}

Chen, Ying ^{[2
]}

Huang, Lingling ^{[2
]}

Liu, Meina ^{[2
]}

Zhang, Yingjia ^{[2
]}

McDonald, Gabrielle ^{[1
]}

Narayanaswamy, Rohini ^{[1
]}

Choe, Sung ^{[1
]}

Chen, Yue ^{[1
]}

Gross, Stefan ^{[1
]}

Cianchetta, Giovanni ^{[1
]}

Padyana, Anil K. ^{[1
]}

Murray, Stuart ^{[1
]}

Liu, Wei ^{[1
]}

Marks, Kevin M. ^{[1
]}

Murtie, Joshua ^{[1
]}

Dorsch, Marion ^{[1
]}

Jin, Shengfang ^{[1
]}

Nagaraja, Nelamangala ^{[1
]}

Biller, Scott A. ^{[1
]}

Roddy, Thomas ^{[1
]}

Popovici-Muller, Janeta ^{[1
,3
]}

Smolen, Gromoslaw A. ^{[1
,4
]}

机构：

[1] Agios Pharmaceut, 88 Sidney St, Cambridge, MA 02139 USA

[2] Shanghai ChemPartner Co Ltd, 998 Halei Rd, Shanghai 201203, Peoples R China

[3] Decibel Therapeut, 1325 Boylston St,Suite 500, Boston, MA 02215 USA

[4] Celsius Therapeut, 215 First St, Cambridge, MA 02142 USA

来源：

NATURE COMMUNICATIONS | 2019年 / 10卷 / 1期

关键词：

SQUALENE EPOXIDASE; LUNG-CANCER; CHOLESTEROL; METABOLISM; SENSITIVITY; ONCOGENE; ASCL1; LEADS; D2O;

D O I：

10.1038/s41467-018-07959-4

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Aberrant metabolism of cancer cells is well appreciated, but the identification of cancer subsets with specific metabolic vulnerabilities remains challenging. We conducted a chemical biology screen and identified a subset of neuroendocrine tumors displaying a striking pattern of sensitivity to inhibition of the cholesterol biosynthetic pathway enzyme squalene epoxidase (SQLE). Using a variety of orthogonal approaches, we demonstrate that sensitivity to SQLE inhibition results not from cholesterol biosynthesis pathway inhibition, but rather surprisingly from the specific and toxic accumulation of the SQLE substrate, squalene. These findings highlight SQLE as a potential therapeutic target in a subset of neuroendocrine tumors, particularly small cell lung cancers.

引用

页数：14

共 50 条

[1] A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition
Christopher E. Mahoney
David Pirman
Victor Chubukov
Taryn Sleger
Sebastian Hayes
Zi Peng Fan
Eric L. Allen
Ying Chen
Lingling Huang
Meina Liu
Yingjia Zhang
Gabrielle McDonald
Rohini Narayanaswamy
Sung Choe
Yue Chen
Stefan Gross
Giovanni Cianchetta
Anil K. Padyana
Stuart Murray
Wei Liu
Kevin M. Marks
Joshua Murtie
Marion Dorsch
Shengfang Jin
Nelamangala Nagaraja
Scott A. Biller
Thomas Roddy
Janeta Popovici-Muller
Gromoslaw A. Smolen
Nature Communications, 10
[2] A chemical biology screen identifies a unique vulnerability of neuroendocrine cancer cells to SQLE inhibition
Mahoney, Christopher
Pirman, David
Chubukov, Victor
Sleger, Taryn
Padyana, Anil
Gross, Stefan
Hayes, Sebastian
Fan, Zi Peng
McDonald, Gabrielle
Chen, Yu
Murtie, Joshua
Cianchetta, Giovanni
Nagaraja, Raj
Narayanaswamy, Rohini
Choe, Sung
Murray, Stuart
Jin, Shengfang
Biller, Scott
Roddy, Thomas
Smolen, Gromoslaw A.
CANCER RESEARCH, 2018, 78 (13)
[3] Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells
Ketola, Kirsi
Kallioniemi, Olli
Iljin, Kristiina
PLOS ONE, 2012, 7 (12):
[4] MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer
C. Kalogirou
J. Linxweiler
P. Schmucker
M. T. Snaebjornsson
W. Schmitz
S. Wach
M. Krebs
E. Hartmann
M. Puhr
A. Müller
M. Spahn
A. K. Seitz
T. Frank
H. Marouf
G. Büchel
M. Eckstein
H. Kübler
M. Eilers
M. Saar
K. Junker
F. Röhrig
B. Kneitz
M. T. Rosenfeldt
A. Schulze
Nature Communications, 12
[5] MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer
Kalogirou, C.
Linxweiler, J.
Schmucker, P.
Snaebjornsson, M. T.
Schmitz, W.
Wach, S.
Krebs, M.
Hartmann, E.
Puhr, M.
Mueller, A.
Spahn, M.
Seitz, A. K.
Frank, T.
Marouf, H.
Buechel, G.
Eckstein, M.
Kuebler, H.
Eilers, M.
Saar, M.
Junker, K.
Roehrig, F.
Kneitz, B.
Rosenfeldt, M. T.
Schulze, A.
NATURE COMMUNICATIONS, 2021, 12 (01)
[6] HIGH-THROUGHPUT CHEMICAL BIOLOGY SCREEN IDENTIFIES ROS INTOLERANCE AS A VULNERABILITY OF MYC-AMPLIFIED/GROUP 3 MEDULLOBLASTOMAS
Yu, Furong
Masoud, Sabran
Nguyen, Brian
Vue, Nusi
Schubert, Simone
Tolliday, Nicola
Sengupta, Soma
Weeraratne, Dilhan
Schreiber, Stuart
Cho, Yoon-Jae
NEURO-ONCOLOGY, 2013, 15 : 50 - 50
[7] An Integrated Chemical Biology Approach Identifies Specific Vulnerability of Ewing's Sarcoma to Combined Inhibition of Aurora Kinases A and B
Winter, Georg E.
Rix, Uwe
Lissat, Andrej
Stukalov, Alexey
Muellner, Markus K.
Bennett, Keiryn L.
Colinge, Jacques
Nijman, Sebastian M.
Kubicek, Stefan
Kovar, Heinrich
Kontny, Udo
Superti-Furga, Giulio
MOLECULAR CANCER THERAPEUTICS, 2011, 10 (10) : 1846 - 1856
[8] Re: MiR-205-Driven Downregulation of Cholesterol Biosynthesis through SQLE-Inhibition Identifies Therapeutic Vulnerability in Aggressive Prostate Cancer Editorial Comment
Taneja, Samir S.
JOURNAL OF UROLOGY, 2022, 207 (05): : 1155 - 1156
[9] An Unbiased Chemical Biology Screen Identifies Agents That Modulate Uptake of Oxidized LDL by Macrophages
Etzion, Yoram
Hackett, Alice
Proctor, Brandon M.
Ren, Jie
Nolan, Bill
Ellenberger, Thomas
Muslin, Anthony J.
CIRCULATION RESEARCH, 2009, 105 (02) : 148 - U91
[10] A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer
Zhang, KeJing
Wei, Juan
Zhang, SheYu
Fei, Liyan
Guo, Lu
Liu, Xueying
Ji, YiShuai
Chen, WenJun
Ciamponi, Felipe E.
Chen, WeiChang
Li, MengXi
Zhai, Jie
Fu, Ting
Massirer, Katlin B.
Yu, Yang
Lupien, Mathieu
Wei, Yong
Arrowsmith, Cheryl. H.
Wu, Qin
Tan, WeiHong
CELL CHEMICAL BIOLOGY, 2024, 31 (11)

← 1 2 3 4 5 →